These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21079193)

  • 1. Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.
    Dubin R; Shlipak M; Li Y; Ix J; de Boer IH; Jenny N; Peralta CA
    Nephrol Dial Transplant; 2011 Jun; 26(6):1903-8. PubMed ID: 21079193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.
    Sjöberg B; Qureshi AR; Heimbürger O; Stenvinkel P; Lind L; Larsson A; Bárány P; Ärnlöv J
    J Intern Med; 2016 Feb; 279(2):173-9. PubMed ID: 26355706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of acculturation and kidney dysfunction among Hispanics and Chinese from the Multi-Ethnic Study of Atherosclerosis (MESA).
    Day EC; Li Y; Diez-Roux A; Kandula N; Moran A; Rosas S; Shlipak MG; Peralta CA
    Nephrol Dial Transplant; 2011 Jun; 26(6):1909-16. PubMed ID: 21051500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.
    Jenny NS; Blumenthal RS; Kronmal RA; Rotter JI; Siscovick DS; Psaty BM
    J Thromb Haemost; 2014 Jun; 12(6):999-1005. PubMed ID: 24628740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.
    Dubin R; Li Y; Ix JH; Shlipak MG; Whooley M; Peralta CA
    Am Heart J; 2012 Feb; 163(2):274-9. PubMed ID: 22305847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.
    Lee R; Shin MH; Kim HN; Lee YH; Choi SW; Ahn HR; Kweon SS
    Int Urol Nephrol; 2017 Nov; 49(11):2027-2033. PubMed ID: 28733767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin-3 detected in human saliva shows limited correlation with biomarkers associated with systemic inflammation.
    Wetterö J; Jönsson F; von Löhneysen S; Kristenson M; Garvin P; Sjöwall C
    APMIS; 2021 Jun; 129(6):304-313. PubMed ID: 33811685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
    Witasp A; Rydén M; Carrero JJ; Qureshi AR; Nordfors L; Näslund E; Hammarqvist F; Arefin S; Kublickiene K; Stenvinkel P
    PLoS One; 2013; 8(5):e63493. PubMed ID: 23658833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin levels in non-eosinophilic versus eosinophilic asthma.
    Gao P; Tang K; Wang M; Yang Q; Xu Y; Wang J; Zhao J; Xie J
    Clin Exp Allergy; 2018 Aug; 48(8):981-989. PubMed ID: 29754456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers.
    Barazzoni R; Palmisano S; Gortan Cappellari G; Giuricin M; Moretti E; Vinci P; Semolic A; Guarnieri G; Zanetti M; Manzini Nd
    Surg Obes Relat Dis; 2016 Jan; 12(1):23-32. PubMed ID: 26277450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of plasma pentraxin 3 and monocyte chemoattractant protein-1 concentrations with cardiovascular disease in patients with chronic kidney disease.
    Nishi K; Imamura T; Kitamura K; Ogawa T; Fujimoto S; Kakitsubata Y; Ishikawa T; Asada Y; Kodama T
    Ren Fail; 2011; 33(4):398-404. PubMed ID: 21529268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study.
    Bansal N; Vittinghoff E; Peralta CA; Shlipak MG; Grubbs V; Jacobs DR; Siscovick D; Steffes M; Carr JJ; Bibbins-Domingo K
    Am J Epidemiol; 2013 Aug; 178(3):410-7. PubMed ID: 23813702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension.
    Buda V; Andor M; Cristescu C; Voicu M; Cochera F; Tuduce P; Petrescu L; Tomescu MC
    Ir J Med Sci; 2017 Aug; 186(3):621-629. PubMed ID: 28220370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: a case-control study.
    Pradeep AR; Kathariya R; Arjun Raju P; Sushma Rani R; Sharma A; Raghavendra NM
    Int Urol Nephrol; 2012 Jun; 44(3):829-39. PubMed ID: 21637988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria.
    Yilmaz MI; Axelsson J; Sonmez A; Carrero JJ; Saglam M; Eyileten T; Caglar K; Kirkpantur A; Celik T; Oguz Y; Vural A; Yenicesu M; Lindholm B; Stenvinkel P
    Clin J Am Soc Nephrol; 2009 Mar; 4(3):535-41. PubMed ID: 19211665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    Peralta CA; Vittinghoff E; Bansal N; Jacobs D; Muntner P; Kestenbaum B; Lewis C; Siscovick D; Kramer H; Shlipak M; Bibbins-Domingo K
    Am J Kidney Dis; 2013 Aug; 62(2):261-6. PubMed ID: 23473985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component.
    Bottazzi B; Vouret-Craviari V; Bastone A; De Gioia L; Matteucci C; Peri G; Spreafico F; Pausa M; D'Ettorre C; Gianazza E; Tagliabue A; Salmona M; Tedesco F; Introna M; Mantovani A
    J Biol Chem; 1997 Dec; 272(52):32817-23. PubMed ID: 9407058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
    Butt N; Bache-Mathiesen LK; Ushakova A; Nordrehaug JE; Jensen SE; Munk PS; Danchin N; Dubois-Rande JL; Hansen HS; Paganelli F; Corvoisier PL; Firat H; Erlinge D; Atar D; Larsen AI
    Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):302-312. PubMed ID: 32403934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnicity and sex modify the association of serum c-reactive protein with microalbuminuria.
    Palmas W; Ma S; Jacobs DR; Arnett D; Jackson S; Olson J; Saad MF; Kronmal R; Kramer H; Barr RG
    Ethn Dis; 2008; 18(3):324-9. PubMed ID: 18785447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: the multi-ethnic study of atherosclerosis (MESA).
    Camacho Á; Larsen B; McClelland RL; Morgan C; Criqui MH; Cushman M; Allison MA
    J Affect Disord; 2014 Aug; 164():165-70. PubMed ID: 24856570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.